131 related articles for article (PubMed ID: 38512610)
1. Letter to Dr. Wang Jian and his team about our paper "Nomogram based on clinical and preoperative CT features for predicting the early recurrence of combined hepatocellular-cholangiocarcinoma: a multicenter study" published on "La radiologia medica".
Liao JY
Radiol Med; 2024 Apr; 129(4):667. PubMed ID: 38512610
[No Abstract] [Full Text] [Related]
2. Letter to the editor Re "Nomogram based on clinical and preoperative CT features for predicting the early recurrence of combined hepatocellular-cholangiocarcinoma: a multicenter study".
Xie Y; Wang J; Zou Y
Radiol Med; 2024 Apr; 129(4):665-666. PubMed ID: 38512607
[No Abstract] [Full Text] [Related]
3. Nomogram based on clinical and preoperative CT features for predicting the early recurrence of combined hepatocellular-cholangiocarcinoma: a multicenter study.
Zheng C; Gu XT; Huang XL; Wei YC; Chen L; Luo NB; Lin HS; Jin-Yuan L
Radiol Med; 2023 Dec; 128(12):1460-1471. PubMed ID: 37747668
[TBL] [Abstract][Full Text] [Related]
4. Synchronously resected double primary hepatic cancer, hepatocellular carcinoma and cholangiocarcinoma.
Fuji N; Taniguchi H; Amaike H; Oka K; Tsuchihashi Y; Urasaki K; Naito K
J Gastroenterol Hepatol; 2005 Jun; 20(6):967-9. PubMed ID: 15946156
[No Abstract] [Full Text] [Related]
5. Comprehensive radiomics nomogram for predicting survival of patients with combined hepatocellular carcinoma and cholangiocarcinoma.
Tang YY; Zhao YN; Zhang T; Chen ZY; Ma XL
World J Gastroenterol; 2021 Nov; 27(41):7173-7189. PubMed ID: 34887636
[TBL] [Abstract][Full Text] [Related]
6. A case of mucinous cholangiocarcinoma showing features of hepatocellular carcinoma.
Kai K; Ide Y; Miyoshi A; Masuda M; Ide T; Kitahara K; Irie H; Nakajima J; Noshiro H; Tokunaga O
Pathol Int; 2013 Aug; 63(8):419-21. PubMed ID: 23957918
[No Abstract] [Full Text] [Related]
7. Contrast-Enhanced Ultrasound-Based Nomogram: A Potential Predictor of Individually Postoperative Early Recurrence for Patients With Combined Hepatocellular-Cholangiocarcinoma.
Guo HL; Lu XZ; Hu HT; Ruan SM; Zheng X; Xie XY; Lu MD; Kuang M; Shen SL; Chen LD; Wang W
J Ultrasound Med; 2022 Aug; 41(8):1925-1938. PubMed ID: 34751450
[TBL] [Abstract][Full Text] [Related]
8. Author's correction. Detection of combined hepatocellular and cholangiocarcinomas on enhanced CT: comparison with histologic findings.
Nishie A
AJR Am J Roentgenol; 2005 Jul; 185(1):281. PubMed ID: 15972440
[No Abstract] [Full Text] [Related]
9. Differentiation of mass-forming intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma: based on the multivariate analysis of contrast-enhanced computed tomography findings.
Zhao YJ; Chen WX; Wu DS; Zhang WY; Zheng LR
Abdom Radiol (NY); 2016 May; 41(5):978-89. PubMed ID: 27193795
[TBL] [Abstract][Full Text] [Related]
10. Distinguishing intrahepatic mass-forming biliary carcinomas from hepatocellular carcinoma by computed tomography and magnetic resonance imaging using the Bayesian method: a bi-center study.
Ichikawa S; Isoda H; Shimizu T; Tamada D; Taura K; Togashi K; Onishi H; Motosugi U
Eur Radiol; 2020 Nov; 30(11):5992-6002. PubMed ID: 32500195
[TBL] [Abstract][Full Text] [Related]
11. Intraductal malignant tumors in the liver mimicking cholangiocarcinoma: Imaging features for differential diagnosis.
Kim AY; Jeong WK
Clin Mol Hepatol; 2016 Mar; 22(1):192-7. PubMed ID: 27044773
[No Abstract] [Full Text] [Related]
12. Differentiation of intrahepatic cholangiocarcinoma from hepatocellular carcinoma in high-risk patients: A predictive model using contrast-enhanced ultrasound.
Chen LD; Ruan SM; Liang JY; Yang Z; Shen SL; Huang Y; Li W; Wang Z; Xie XY; Lu MD; Kuang M; Wang W
World J Gastroenterol; 2018 Sep; 24(33):3786-3798. PubMed ID: 30197484
[TBL] [Abstract][Full Text] [Related]
13. Prediction of microvascular invasion in combined hepatocellular-cholangiocarcinoma based on preoperative contrast-enhanced CT and clinical data.
Zhang J; Dong W; Li Y; Fu J; Jia N
Eur J Radiol; 2023 Jun; 163():110839. PubMed ID: 37121101
[TBL] [Abstract][Full Text] [Related]
14. Small intrahepatic peripheral cholangiocarcinomas as mimics of hepatocellular carcinoma in multiphasic CT.
Mendiratta-Lala M; Park H; Kolicaj N; Mendiratta V; Bassi D
Abdom Radiol (NY); 2017 Jan; 42(1):171-178. PubMed ID: 27590067
[TBL] [Abstract][Full Text] [Related]
15. DCE-MRI based radiomics nomogram for preoperatively differentiating combined hepatocellular-cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma.
Zhou Y; Zhou G; Zhang J; Xu C; Zhu F; Xu P
Eur Radiol; 2022 Jul; 32(7):5004-5015. PubMed ID: 35128572
[TBL] [Abstract][Full Text] [Related]
16. Recurrence patterns of combined hepatocellular-cholangiocarcinoma on enhanced computed tomography.
Shin CI; Lee JM; Kim SH; Choi JY; Lee JY; Han JK; Jo SY; Choi BI
J Comput Assist Tomogr; 2007; 31(1):109-15. PubMed ID: 17259842
[TBL] [Abstract][Full Text] [Related]
17. A Ring in the Liver.
Xu J; Liang X; Cai X
Am J Gastroenterol; 2021 Jan; 116(1):220-222. PubMed ID: 32868632
[No Abstract] [Full Text] [Related]
18. Combined hepatocellular carcinoma and cholangiocarcinoma with high F-18 fluorodeoxyglucose positron emission tomographic uptake.
Shiomi S; Sasaki N; Kawashima D; Jomura H; Fukuda T; Kuroki T; Koyama K; Kawabe J; Ochi H
Clin Nucl Med; 1999 May; 24(5):370-1. PubMed ID: 10232488
[No Abstract] [Full Text] [Related]
19. CT-based clinico-radiological nomograms for prognosis prediction in patients with intrahepatic mass-forming cholangiocarcinoma: a multi-institutional study.
Jiao CY; Zhang H; Ji GW; Xu Q; Lu M; Zhang B; Yang Y; Wang XH; Li XC
Eur Radiol; 2022 Dec; 32(12):8326-8338. PubMed ID: 35708837
[TBL] [Abstract][Full Text] [Related]
20. Surgery for mixed hepatocellular and cholangiocellular carcinoma.
Uenishi T; Hirohashi K; Shuto T; Yamamoto T; Kubo S; Tanaka H; Ikebe T; Kinoshita H
Hepatogastroenterology; 2000; 47(33):832-4. PubMed ID: 10919041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
